Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation

Biochimica et Biophysica Acta - General Subjects

Volumn 1760, Issue 11, 2006, Pages 1657-1666

  Notas, George ^a   Nifli, Artemissia Phoebe ^a   Kampa, Marilena ^a   Vercauteren, Joseph ^b   Kouroumalis, Elias ^a   Castanas, Elias ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIV MONTPELLIER   (France)

Author keywords

Apoptosis; Cell cycle; Hepatocellular carcinoma; Nitric oxide (NO); Nitric oxide synthase (NOS); Resveratrol

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RESVERATROL;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL PROLIFERATION; G1 PHASE; G2 PHASE; HUMANS; LIVER NEOPLASMS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN SPECIES; STILBENES; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 33750513819     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.09.010     Document Type: Article

References (74)

1. Soleas G.J., Diamandis E.P., and Goldberg D.M. Wine as a biological fluid: history, production, and role in disease prevention. J. Clin. Lab. Anal. 11 (1997) 287-313
2. Langcake P., and Pryce R. The production of resveratrol by Vitis vinifera and other members of the Vitaseae as a response to infection or injury. Physiol. Plant Pathol. 9 (1976) 77-86
3. Creasy L., and Coffee M. Phytoalexin production potential of grape berries. J. Am. Soc. Hortic. Sci. 113 (1988) 230-234
4. Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?. Eur. J. Endocrinol. 138 (1998) 619-620
5. Sun A.Y., Simonyi A., and Sun G.Y. The "French Paradox" and beyond: neuroprotective effects of polyphenols. Free Radical Biol. Med. 32 (2002) 314-318
6. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., and Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
7. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., and Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 24 (2004) 2783-2840
8. Bertelli A., Bertelli A.A., Gozzini A., and Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp. Clin. Res. 24 (1998) 133-138
9. Vitrac X., Desmouliere A., Brouillaud B., Krisa S., Deffieux G., Barthe N., Rosenbaum J., and Merillon J.M. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 72 (2003) 2219-2233
10. Kaldas M.I., Walle U.K., and Walle T. Resveratrol transport and metabolism by human intestinal Caco-2 cells. J. Pharm. Pharmacol. 55 (2003) 307-312
11. Goldberg D.M., Yan J., and Soleas G.J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 36 (2003) 79-87
12. Meng X., Maliakal P., Lu H., Lee M.J., and Yang C.S. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J. Agric. Food Chem. 52 (2004) 935-942
13. Carbo N., Costelli P., Baccino F.M., Lopez-Soriano F.J., and Argiles J.M. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem. Biophys. Res. Commun. 254 (1999) 739-743
14. Sun Z.J., Pan C.E., Liu H.S., and Wang G.J. Anti-hepatoma activity of resveratrol in vitro. World J. Gastroenterol. 8 (2002) 79-81
15. Delmas D., Jannin B., Cherkaoui Malki M., and Latruffe N. Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines. Oncol. Rep. 7 (2000) 847-852
16. De Ledinghen V., Monvoisin A., Neaud V., Krisa S., Payrastre B., Bedin C., Desmouliere A., Bioulac-Sage P., and Rosenbaum J. Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells. Int. J. Oncol. 19 (2001) 83-88
17. Kozuki Y., Miura Y., and Yagasaki K. Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action. Cancer Lett. 167 (2001) 151-156
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
19. Rothe G., and Valet G. Flow cytometric assays of oxidative burst activity in phagocytes. Methods Enzymol. 233 (1994) 539-548
20. Notas G., Xidakis C., Valatas V., Kouroumalis A., and Kouroumalis E. Levels of circulating endothelin-1 and nitrates/nitrites in patients with virus-related hepatocellular carcinoma. J. Viral Hepatitis 8 (2001) 63-69
21. Kopec K.K., and Carroll R.T. Phagocytosis is regulated by nitric oxide in murine microglia. Nitric Oxide 4 (2000) 103-111
22. Kojima H., Nakatsubo N., Kikuchi K., Kawahara S., Kirino Y., Nagoshi H., Hirata Y., and Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal. Chem. 70 (1998) 2446-2453
23. Kampa M., Alexaki V., Notas G., Nifli A., Nistikaki A., Hatzoglou A., Bakogeorgou E., Kouimtzoglou E., Blekas G., Boskou D., Gravanis A., and Castanas E. Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res. 6 (2004) R63-R74
24. Alexaki V.I., Charalampopoulos I., Kampa M., Vassalou H., Theodoropoulos P., Stathopoulos E.N., Hatzoglou A., Gravanis A., and Castanas E. Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation. FASEB J. 18 (2004) 1594-1596
25. Hofseth L.J., Hussain S.P., Wogan G.N., and Harris C.C. Nitric oxide in cancer and chemoprevention. Free Radical Biol. Med. 34 (2003) 955-968
26. McNaughton L., Puttagunta L., Martinez-Cuesta M.A., Kneteman N., Mayers I., Moqbel R., Hamid Q., and Radomski M.W. Distribution of nitric oxide synthase in normal and cirrhotic human liver. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 17161-17166
27. Aziz M.H., Kumar R., and Ahmad N. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int. J. Oncol. 23 (2003) 17-28
28. Schneider Y., Chabert P., Stutzmann J., Coelho D., Fougerousse A., Gosse F., Launay J.F., Brouillard R., and Raul F. Resveratrol analog (Z)-3,5,4′-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. Int. J. Cancer 107 (2003) 189-196
29. Damianaki A., Bakogeorgou E., Kampa M., Notas G., Hatzoglou A., Panagiotou S., Gemetzi C., Kouroumalis E., Martin P.M., and Castanas E. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J. Cell. Biochem. 78 (2000) 429-441
30. Kampa M., Hatzoglou A., Notas G., Damianaki A., Bakogeorgou E., Gemetzi C., Kouroumalis E., Martin P.M., and Castanas E. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr. Cancer 37 (2000) 223-233
31. Shioda T., Chesnes J., Coser K.R., Zou L., Hur J., Dean K.L., Sonnenschein C., Soto A.M., and Isselbacher K.J. Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 12033-12038
32. Clement M.V., Hirpara J.L., Chawdhury S.H., and Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92 (1998) 996-1002
33. Bernhard D., Tinhofer I., Tonko M., Hubl H., Ausserlechner M.J., Greil R., Kofler R., and Csordas A. Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ. 7 (2000) 834-842
34. Delmas D., Rebe C., Lacour S., Filomenko R., Athias A., Gambert P., Cherkaoui-Malki M., Jannin B., Dubrez-Daloz L., Latruffe N., and Solary E. Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J. Biol. Chem. 278 (2003) 41482-41490
35. Zheng J., and Ramirez V.D. Piceatannol, a stilbene phytochemical, inhibits mitochondrial F0F1-ATPase activity by targeting the F1 complex. Biochem. Biophys. Res. Commun. 261 (1999) 499-503
36. Dorrie J., Gerauer H., Wachter Y., and Zunino S.J. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res. 61 (2001) 4731-4739
37. Kotha A., Sekharam M., Cilenti L., Siddiquee K., Khaled A., Zervos A.S., Carter B., Turkson J., and Jove R. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol. Cancer Ther. 5 (2006) 621-629
38. Estrov Z., Shishodia S., Faderl S., Harris D., Van Q., Kantarjian H.M., Talpaz M., and Aggarwal B.B. Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 102 (2003) 987-995
39. Hsieh T.C., Burfeind P., Laud K., Backer J.M., Traganos F., Darzynkiewicz Z., and Wu J.M. Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int. J. Oncol. 15 (1999) 245-252
40. Wolter F., Akoglu B., Clausnitzer A., and Stein J. Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J. Nutr. 131 (2001) 2197-2203
41. Ahmad N., Adhami V.M., Afaq F., Feyes D.K., and Mukhtar H. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin. Cancer Res. 7 (2001) 1466-1473
42. Liang Y.C., Tsai S.H., Chen L., Lin-Shiau S.Y., and Lin J.K. Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochem. Pharmacol. 65 (2003) 1053-1060
43. Larrosa M., Tomas-Barberan F.A., and Espin J.C. Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells. J. Agric. Food Chem. 51 (2003) 4576-4584
44. Kuwajerwala N., Cifuentes E., Gautam S., Menon M., Barrack E.R., and Reddy G.P. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis. Cancer Res. 62 (2002) 2488-2492
45. Adhami V.M., Afaq F., and Ahmad N. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells. Biochem. Biophys. Res. Commun. 288 (2001) 579-585
46. Huang C., Ma W.Y., Goranson A., and Dong Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20 (1999) 237-242
47. Hsieh T.C., Juan G., Darzynkiewicz Z., and Wu J.M. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 59 (1999) 2596-2601
48. Lu J., Ho C.H., Ghai G., and Chen K.Y. Resveratrol analog, 3,4,5,4′-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts. Carcinogenesis 22 (2001) 321-328
49. Nifli A.P., Bosson-Kouame A., Papadopoulou N., Kogia C., Kampa M., Castagnino C., Stournaras C., Vercauteren J., and Castanas E. Monomeric and oligomeric flavanols are agonists of membrane androgen receptors. Exp. Cell Res. 309 (2005) 329-339
50. Yen G.C., and Lai H.H. Inhibition of reactive nitrogen species effects in vitro and in vivo by isoflavones and soy-based food extracts. J. Agric. Food Chem. 51 (2003) 7892-7900
51. Iishi H., Tatsuta M., Baba M., Yamamoto R., Uehara H., and Nakaizumi A. Inhibition of experimental gastric carcinogenesis, induced by N-methyl-N′-nitro-N-nitrosoguanidine in rats, by sodium nitroprusside, a nitric oxide generator. Eur. J. Cancer 34 (1998) 554-557
52. Jenkins D.C., Charles I.G., Thomsen L.L., Moss D.W., Holmes L.S., Baylis S.A., Rhodes P., Westmore K., Emson P.C., and Moncada S. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 4392-4396
53. Thomas W.J., Thomas D.L., Knezetic J.A., and Adrian T.E. The role of oxygen-derived free radicals and nitric oxide in cytokine-induced antiproliferation of pancreatic cancer cells. Pancreas 24 (2002) 161-168
54. Thomsen L.L., Lawton F.G., Knowles R.G., Beesley J.E., Riveros-Moreno V., and Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 54 (1994) 1352-1354
55. Martin-Sanz P., Hortelano S., Callejas N.A., Goren N., Casado M., Zeini M., and Bosca L. Nitric oxide in liver inflammation and regeneration. Metab. Brain Dis. 17 (2002) 325-334
56. Vodovotz Y., Kim P.K., Bagci E.Z., Ermentrout G.B., Chow C.C., Bahar I., and Billiar T.R. Inflammatory modulation of hepatocyte apoptosis by nitric oxide: in vivo, in vitro, and in silico studies. Curr. Mol. Med. 4 (2004) 753-762
57. Genius J., and Fandrey J. Nitric oxide affects the production of reactive oxygen species in hepatoma cells: implications for the process of oxygen sensing. Free Radical Biol. Med. 29 (2000) 515-521
58. Hirakawa M., Oike M., Masuda K., and Ito Y. Tumor cell apoptosis by irradiation-induced nitric oxide production in vascular endothelium. Cancer Res. 62 (2002) 1450-1457
59. Jiang X.M., Zheng D.L., and Lin J.Y. Effects of nitric oxide on mitochondrial permeability transition and cytochrome C of human hepatocellular carcinoma cell lines. Zhongguo Yixue Kexueyuan Xuebao 26 (2004) 519-523
60. Lucas Sd S., Lopez-Alcorocho J.M., Bartolome J., and Carreno V. Nitric oxide and TGF-beta1 inhibit HNF-4alpha function in HEPG2 cells. Biochem. Biophys. Res. Commun. 321 (2004) 688-694
61. Chung E.Y., Kim B.H., Lee M.K., Yun Y.P., Lee S.H., Min K.R., and Kim Y. Anti-inflammatory effect of the oligomeric stilbene alpha-Viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase. Planta Med. 69 (2003) 710-714
62. Kageura T., Matsuda H., Morikawa T., Toguchida I., Harima S., Oda M., and Yoshikawa M. Inhibitors from rhubarb on lipopolysaccharide-induced nitric oxide production in macrophages: structural requirements of stilbenes for the activity. Bioorg. Med. Chem. 9 (2001) 1887-1893
63. Holian O., Wahid S., Atten M.J., and Attar B.M. Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide. Am. J. Physiol.: Gastrointest. Liver Physiol. 282 (2002) G809-G816
64. Wallerath T., Deckert G., Ternes T., Anderson H., Li H., Witte K., and Forstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106 (2002) 1652-1658
65. Hattori R., Otani H., Maulik N., and Das D.K. Pharmacological preconditioning with resveratrol: role of nitric oxide. Am. J. Physiol.: Heart Circ. Physiol. 282 (2002) H1988-H1995
66. Holian O., Wahid S., Atten M.J., and Attar B.M. Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide. Am. J. Physiol.: Gastrointest. Liver Physiol. 282 (2002) G809-G816
67. Chan M.M., Mattiacci J.A., Hwang H.S., Shah A., and Fong D. Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem. Pharmacol. 60 (2000) 1539-1548
68. Cho D.I., Koo N.Y., Chung W.J., Kim T.S., Ryu S.Y., Im S.Y., and Kim K.M. Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: structural requirements and mechanism of action. Life Sci. 71 (2002) 2071-2082
69. Tsai S.H., Lin-Shiau S.Y., and Lin J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol. 126 (1999) 673-680
70. Nifli A.-.P., Kampa M., Alexaki V., Notas G., and Castanas E. Polyphenol interaction with the T47D human breast cancer cell line. J. Dairy Res. 72 S1 (2005) 44-50
71. Kuo P.L., Chiang L.C., and Lin C.C. Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci. 72 (2002) 23-34
72. Mortensen K., Skouv J., Hougaard D.M., and Larsson L.I. Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J. Biol. Chem. 274 (1999) 37679-37684
73. Uchida Y., Yamazaki H., Watanabe S., Hayakawa K., Meng Y., Hiramatsu N., Kasai A., Yamauchi K., Yao J., and Kitamura M. Enhancement of NF-kappaB activity by resveratrol in cytokine-exposed mesangial cells. Clin. Exp. Immunol. 142 (2005) 76-83
74. Ilan E., Tirosh O., and Madar Z. Triacylglycerol-mediated oxidative stress inhibits nitric oxide production in rat isolated hepatocytes. J. Nutr. 135 (2005) 2090-2095